1. Home
  2. MIGI vs NSRX Comparison

MIGI vs NSRX Comparison

Compare MIGI & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mawson Infrastructure Group Inc.

MIGI

Mawson Infrastructure Group Inc.

HOLD

Current Price

$4.71

Market Cap

33.6M

Sector

Finance

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$2.88

Market Cap

32.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIGI
NSRX
Founded
2012
2019
Country
United States
Israel
Employees
N/A
7
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.6M
32.2M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
MIGI
NSRX
Price
$4.71
$2.88
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
167.5K
40.7K
Earning Date
05-14-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,754,085.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$1.98
52 Week High
$15.80
$9.99

Technical Indicators

Market Signals
Indicator
MIGI
NSRX
Relative Strength Index (RSI) 49.42 49.51
Support Level $3.95 $2.04
Resistance Level $5.20 $3.58
Average True Range (ATR) 1.19 0.30
MACD -0.15 -0.01
Stochastic Oscillator 23.12 25.51

Price Performance

Historical Comparison
MIGI
NSRX

About MIGI Mawson Infrastructure Group Inc.

Mawson Infrastructure Group Inc is focused on digital infrastructure platforms. It designs, builds and operates next-generation digital infrastructure platforms for enterprise customers and for its own purposes. The company provides services spanning AI, HPC, digital assets including Bitcoin mining, and other intensive compute applications. The company delivers both self-mining operations and colocation services to enterprise customers with a vertically integrated infrastructure model built for scalability and efficiency. The company also has an energy management business, which utilizes software and analysis, to generate revenue by participating in energy management programs. It operates as one energy management and digital asset mining segment.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: